Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by longondmxon Aug 08, 2014 3:47pm
315 Views
Post# 22823727

this should not come as a surprise!

this should not come as a surprise!And I have been saying this for the last few months when the stock was drifitng down to the 30's..  I'd say we are now on our way and this looks like it has legs.....

Why no surprise?

Well, significant insider buying in the last few months. 

Pipeline with 3 products currrently worth at least $50 million each (excluding any  possible benefit from the lawsuit). 

The company has a market cap of only $40 million - should without any strecth be in the multi hundred million.

Company is profitable and cashflow positive.  How many penny stock bios can say that?

And many more reasons why this should be much higher (feel free to expand).  I'd say we should easily be in the mutidollar range.  In a year, we should be over $2...maybe even as high as $5.  Someone mark this post and touch base with me a year from now...I am sure we be over $2.
Bullboard Posts